WuXi Biologics (Cayman) Inc. (WXXWY)
USD 4.3
(-1.15%)
USD 4.3
(-1.15%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 3.83 Billion CNY | 162.05% |
| 2022 | 1.46 Billion CNY | 128.19% |
| 2021 | 640.51 Million CNY | -65.14% |
| 2020 | 1.83 Billion CNY | 31.71% |
| 2019 | 1.39 Billion CNY | 0.0% |
| 2018 | - CNY | 0.0% |
| 2017 | - CNY | -100.0% |
| 2016 | 895.65 Million CNY | 0.0% |
| 2015 | - CNY | 0.0% |
| 2014 | - CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 1.26 Billion CNY | 0.0% |
| 2023 Q4 | 3.83 Billion CNY | 0.0% |
| 2023 FY | 3.83 Billion CNY | 162.05% |
| 2023 Q2 | 1.65 Billion CNY | 0.0% |
| 2022 Q2 | 531.89 Million CNY | 0.0% |
| 2022 Q4 | 1.46 Billion CNY | 0.0% |
| 2022 FY | 1.46 Billion CNY | 128.19% |
| 2021 FY | 640.51 Million CNY | -65.14% |
| 2021 Q4 | 640.51 Million CNY | 0.0% |
| 2021 Q2 | 2.07 Billion CNY | 0.0% |
| 2020 Q2 | 2.21 Billion CNY | 0.0% |
| 2020 FY | 1.83 Billion CNY | 31.71% |
| 2020 Q4 | 1.83 Billion CNY | 0.0% |
| 2019 Q4 | 1.39 Billion CNY | 0.0% |
| 2019 FY | 1.39 Billion CNY | 0.0% |
| 2019 Q2 | 216.55 Million CNY | 0.0% |
| 2018 Q4 | - CNY | 0.0% |
| 2018 Q2 | - CNY | 0.0% |
| 2018 FY | - CNY | 0.0% |
| 2017 Q2 | 896 Million CNY | 0.0% |
| 2017 Q4 | - CNY | 0.0% |
| 2017 FY | - CNY | -100.0% |
| 2016 Q4 | 895.65 Million CNY | 0.0% |
| 2016 FY | 895.65 Million CNY | 0.0% |
| 2015 Q2 | - CNY | 0.0% |
| 2015 Q1 | - CNY | 0.0% |
| 2015 Q4 | - CNY | 0.0% |
| 2015 FY | - CNY | 0.0% |
| 2015 Q3 | - CNY | 0.0% |
| 2014 Q3 | - CNY | 0.0% |
| 2014 Q4 | - CNY | 0.0% |
| 2014 FY | - CNY | 0.0% |
| 2014 Q1 | - CNY | 0.0% |
| 2014 Q2 | - CNY | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | - USD | -Infinity% |
| Nanobac Pharmaceuticals, Incorporated | - USD | -Infinity% |
| SQZ Biotechnologies Company | 20.9 Million USD | -18217.715% |
| Evofem Biosciences, Inc. | 8000.00 USD | -47875537.5% |
| Santhera Pharmaceuticals Holding AG | 1.75 Million USD | -218076.976% |
| Mesoblast Limited | 100.29 Million USD | -3718.788% |
| Propanc Biopharma, Inc. | 58.64 Thousand USD | -6531142.113% |
| Genus plc | 228.2 Million USD | -1578.375% |
| VioQuest Pharmaceuticals, Inc. | - USD | -Infinity% |
| CNBX Pharmaceuticals Inc. | - USD | -Infinity% |
| Marizyme, Inc. | 667.12 Thousand USD | -574009.505% |
| ContraFect Corporation | 2.21 Million USD | -173205.475% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| PsyBio Therapeutics Corp. | - USD | -Infinity% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.4 Million USD | -272902.935% |
| Intellipharmaceutics International Inc. | - USD | -Infinity% |
| AXIM Biotechnologies, Inc. | 5.42 Million USD | -70480.763% |
| MultiCell Technologies, Inc. | 36.43 USD | -10513453097.914% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| RVL Pharmaceuticals plc | 55.61 Million USD | -6787.095% |
| EV Biologics, Inc. | - USD | -Infinity% |
| Q BioMed Inc. | - USD | -Infinity% |
| Emmaus Life Sciences, Inc. | 2.22 Million USD | -171959.793% |
| Neon Bloom, Inc. | - USD | -Infinity% |
| Mosaic ImmunoEngineering Inc. | 1.22 Million USD | -311701.742% |
| Biomind Labs Inc. | - USD | -Infinity% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 166.1 Million USD | -2205.801% |
| Oncotelic Therapeutics, Inc. | 1.89 Million USD | -201644.301% |
| Skye Bioscience, Inc. | 171.23 Thousand USD | -2236687.362% |
| Therapeutic Solutions International, Inc. | 5512.00 USD | -69485585.776% |
| THC Farmaceuticals, Inc. | - USD | -Infinity% |
| Arch Therapeutics, Inc. | - USD | -Infinity% |
| IMV Inc. | 27.39 Million USD | -13879.017% |
| Acro Biomedical Co., Ltd. | - USD | -Infinity% |
| Curative Biotechnology, Inc. | - USD | -Infinity% |
| GB Sciences, Inc. | 322 Thousand USD | -1189356.832% |
| Alpha Cognition Inc. | - USD | -Infinity% |
| HST Global, Inc. | - USD | -Infinity% |
| CSL Limited | 11.23 Billion USD | 65.922% |
| Halberd Corporation | 150 Thousand USD | -2553267.333% |
| Enzolytics Inc. | - USD | -Infinity% |
| Resverlogix Corp. | - USD | -Infinity% |
| Affymax, Inc. | - USD | -Infinity% |
| SYBLEU INC | 300 Thousand USD | -1276583.667% |
| Nuo Therapeutics, Inc. | 164.2 Thousand USD | -2332381.35% |
| argenx SE | 15.35 Million USD | -24844.972% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | 20.31 Million USD | -18756.1% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | - USD | -Infinity% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | - USD | -Infinity% |
| Zenith Capital Corp. | 4456.00 USD | -85952570.557% |
| Genscript Biotech Corporation | 287.12 Million USD | -1233.913% |
| Ember Therapeutics, Inc. | - USD | -Infinity% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 126.3 Thousand USD | -3032354.751% |
| WPD Pharmaceuticals Inc. | 229.29 Thousand USD | -1670288.72% |
| American Oriental Bioengineering, Inc. | 554.59 Thousand USD | -690509.459% |
| Provectus Biopharmaceuticals, Inc. | 25.29 Thousand USD | -15139039.887% |
| Adynxx, Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | - USD | -Infinity% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 8.26 Million USD | -46246.212% |
| Cotinga Pharmaceuticals Inc. | - USD | -Infinity% |
| BioStem Technologies, Inc. | 265.63 Thousand USD | -1441747.272% |
| ONE Bio Corp. | 592.19 Thousand USD | -646651.762% |
| Reve Technologies, Inc. | 1064.00 USD | -359967099.248% |
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| Wesana Health Holdings Inc. | - USD | -Infinity% |
| Agentix Corp. | - USD | -Infinity% |
| LadRx Corporation | - USD | -Infinity% |
| Cell Source, Inc. | - USD | -Infinity% |
| ProtoKinetix, Incorporated | - USD | -Infinity% |
| Regen BioPharma, Inc. | 149.61 Thousand USD | -2559854.951% |
| Regen BioPharma, Inc. | 149.61 Thousand USD | -2559854.951% |
| NovAccess Global Inc. | - USD | -Infinity% |
| Endonovo Therapeutics, Inc. | - USD | -Infinity% |
| Itoco Inc. | - USD | -Infinity% |
| Rasna Therapeutics, Inc. | - USD | -Infinity% |
| Pathfinder Cell Therapy, Inc. | - USD | -Infinity% |
| Kadimastem Ltd | 229.69 Thousand USD | -1667379.788% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Institute of Biomedical Research Corp. | - USD | -Infinity% |
| CytoDyn Inc. | 141 Thousand USD | -2716248.227% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| Mobile Lads Corp. | - USD | -Infinity% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Qrons Inc. | 80 Thousand USD | -4787463.75% |
| Alseres Pharmaceuticals, Inc. | 7.81 Million USD | -48877.885% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | - USD | -Infinity% |
| Rebus Holdings, Inc. | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 369.04 Thousand USD | -1037716.388% |
| International Stem Cell Corporation | 445 Thousand USD | -860585.618% |
| Bioxytran, Inc. | - USD | -Infinity% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | - USD | -Infinity% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 8.15 Million USD | -46894.491% |
| Adhera Therapeutics, Inc. | - USD | -Infinity% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | - USD | -Infinity% |
| Innovation Pharmaceuticals Inc. | 457 Thousand USD | -837985.558% |
| Neutra Corp. | - USD | -Infinity% |
| Windtree Therapeutics, Inc. | 1.16 Million USD | -329792.42% |
| PureTech Health plc | 18.25 Million USD | -20886.581% |
| Coeptis Therapeutics, Inc. | 150 Thousand USD | -2553267.333% |
| IXICO plc | 275 Thousand USD | -1392645.818% |
| IntelGenx Technologies Corp. | 11.83 Million USD | -32251.136% |
| Gelesis Holdings, Inc. | 26.3 Million USD | -14457.95% |
| CSL Limited | 11.23 Billion USD | 65.922% |
| Cellectis S.A. | 36.21 Million USD | -10476.995% |